ZAVESCA Side Effects

7024719-1 | Epilepsy
on Sep 16, 2010 Female patient from ITALY , 67 years of age, was diagnosed with niemann-pick disease and was treated with Zavesca (View Usage). Patient experienced the following unwanted or unexpected effects: epilepsy (What is epilepsy?). Zavesca dosage: Oral. During the same period patient was treated with PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ).

7021050-5 | Abdominal Pain, Back Pain, Bone Infarction, Bone Lesion, Bone Pain, Diarrhoea, Dry Skin, Erectile Dysfunction, Headache
Patient was taking Zavesca (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), back pain (What is back pain?), bone infarction, bone lesion, bone pain, diarrhoea, dry skin, erectile dysfunction (What is erectile dysfunction?), headache (What is headache?) on Sep 09, 2010 from FRANCE Additional patient health information: Male patient , 36 years of age, weighting 168.4 lb, was diagnosed with gaucher's disease and. Zavesca dosage: 100 Mg, Tid, Oral.

7021030-X | Asthenia, Diarrhoea, Disease Progression, Disturbance In Attention, Dizziness, Gaucher's Disease, Haemoglobin Decreased, Headache
Adverse event was reported on Sep 10, 2010 by a Female patient taking Zavesca (View Usage) (Dosage: 100 Mg, Tid, Oral) was diagnosed with gaucher's disease and. Location: FRANCE , 28 years of age, weighting 176.4 lb, After Zavesca was administered, patient had the following side effects: asthenia, diarrhoea, disease progression, disturbance in attention, dizziness (What is dizziness?), gaucher's disease, haemoglobin decreased, headache (What is headache?).

7007253-4 | Angiotensin Converting Enzyme Increased, Back Pain, Blood Acid Phosphatase Increased, Bone Pain, Chitotriosidase Increased, Disease Progression, Economic Problem, Fatigue, Fibrin D Dimer Increased
on Aug 20, 2010 Female patient from UNITED STATES , 44 years of age, weighting 218.0 lb, was diagnosed with gaucher's disease and was treated with Zavesca (View Usage). Patient experienced the following unwanted or unexpected effects: angiotensin converting enzyme increased, back pain (What is back pain?), blood acid phosphatase increased, bone pain, chitotriosidase increased, disease progression, economic problem, fatigue, fibrin d dimer increased. Zavesca dosage: 100 Mg, Tid, Oral. During the same period patient was treated with CEREZYME (View Cerezyme Review and Cerezyme Label ).


6973919-5 | Aggression, Anxiety, Hallucination, Logorrhoea
on Aug 24, 2010 Male patient from SLOVAKIA (Slovak Republic) , 20 years of age, was diagnosed with niemann-pick disease and was treated with Zavesca (View Usage). Patient had the following side effects: aggression, anxiety (What is anxiety?), hallucination, logorrhoea. Zavesca dosage: 200 Mg Tid, Oral; 100 Mg Tid; 200 Mg, Tid, Oral; 1000 Mg , Tid, Oral. During the same period patient was treated with CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ). Patient was hospitalized.

6969022-0 | Demyelinating Polyneuropathy, Diarrhoea, Epilepsy, Flatulence, Foot Fracture, Guillain-barre Syndrome, Joint Sprain, Mental Impairment, Neuropathy Peripheral
Patient was taking Zavesca (View Usage). After Zavesca was administered, patient had the following side effects: demyelinating polyneuropathy, diarrhoea, epilepsy (What is epilepsy?), flatulence, foot fracture, guillain-barre syndrome (What is guillain-barre syndrome?), joint sprain, mental impairment, neuropathy peripheral on Aug 22, 2010 from FRANCE Additional patient health information: Female patient , 17 years of age, weighting 106.9 lb, was diagnosed with gaucher's disease and. Zavesca dosage: 100 Mg, Tid, Oral, 100 Mg, Qd, Oral. During the same period patient was treated with LAMICTAL (View Lamictal Review and Lamictal Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), KEPPRA (View Keppra Review and Keppra Label ). Patient was hospitalized.

6917566-X | Abdominal Pain, Activities Of Daily Living Impaired, Back Pain, Bone Pain, Convulsion, Diarrhoea, Epilepsy, Hepatic Steatosis
Adverse event was reported on Jul 21, 2010 by a Male patient taking Zavesca (View Usage) (Dosage: 100 Mg, Bid, Oral; 100 Mg, Qd, Oral; 100 Mg, Tid, Oral; 400 Mg, Tid, Oral) was diagnosed with gaucher's disease and. Location: FRANCE , 29 years of age, weighting 187.4 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), activities of daily living impaired, back pain (What is back pain?), bone pain, convulsion, diarrhoea, epilepsy (What is epilepsy?), hepatic steatosis. During the same period patient was treated with CEREZYME (View Cerezyme Review and Cerezyme Label ), IMODIUM (View Imodium Review and Imodium Label ), ZONEGRAN (View Zonegran Review and Zonegran Label ), DEPAKENE (View Depakene Review and Depakene Label ). Patient was hospitalized.

6915880-5 | Disease Progression, Dyskinesia, Niemann-pick Disease, Pneumonia
on Jul 21, 2010 Female patient from AUSTRIA , 49 years of age, weighting 110.2 lb, was diagnosed with niemann-pick disease and was treated with Zavesca (View Usage). Patient had the following side effects: disease progression, dyskinesia, niemann-pick disease, pneumonia (What is pneumonia?). Zavesca dosage: 200 Mg, Tid, Oral; 100 Mg, Tid, Oral. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

6883067-0 | Convulsion
on Jul 21, 2010 Male patient from BRAZIL , 13 years of age, was diagnosed with niemann-pick disease and was treated with Zavesca (View Usage). After Zavesca was administered, patient had the following side effects: convulsion. Zavesca dosage: 100 Mg, Qd, Oral. Patient was hospitalized.

6874890-7 | Ataxia, Decreased Activity, Disease Progression, Epilepsy, Hypotonia, Niemann-pick Disease, Tremor
Patient was taking Zavesca (View Usage). Patient experienced the following unwanted or unexpected effects: ataxia (What is ataxia?), decreased activity, disease progression, epilepsy (What is epilepsy?), hypotonia, niemann-pick disease, tremor on Jul 08, 2010 from ITALY Additional patient health information: Male patient , weighting 26.24 lb, was diagnosed with niemann-pick disease and. Zavesca dosage: 50 Mg, Bid, Oral; 25 Mg, Od, Oral; 50 Mg, Od, Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized and became disabled.

6815250-4 | Ataxia, Disease Progression, Hypotonia, Niemann-pick Disease, Tremor
Adverse event was reported on Jun 15, 2010 by a Male patient taking Zavesca (View Usage) (Dosage: 50 Mg, Bid, Oral) was diagnosed with niemann-pick disease and. Location: ITALY , weighting 26.24 lb, Patient had the following side effects: ataxia (What is ataxia?), disease progression, hypotonia, niemann-pick disease, tremor. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized and became disabled.

6787388-1 | Cerebrovascular Accident, Off Label Use, Respiratory Tract Infection, Septic Embolus
on Jun 14, 2010 Male patient from BRAZIL , child 4 years of age, was diagnosed with tay-sachs disease and was treated with Zavesca (View Usage). After Zavesca was administered, patient had the following side effects: cerebrovascular accident, off label use, respiratory tract infection, septic embolus. Zavesca dosage: 100 Mg, Tid, Oral. During the same period patient was treated with VIGABATRIN (VIGABATRIN) (View Vigabatrin (vigabatrin) Review and Vigabatrin (vigabatrin) Label ), PRIMIDONE (View Primidone Review and Primidone Label ).

6759519-0 | Gastrointestinal Disorder, Growth Retardation
on May 20, 2010 Female patient from FRANCE , child 3 years of age, was diagnosed with niemann-pick disease and was treated with Zavesca (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal disorder, growth retardation. Zavesca dosage: 300 Mg, Oral.

6750623-X | Escherichia Urinary Tract Infection, Haematuria
Patient was taking Zavesca (View Usage). Patient had the following side effects: escherichia urinary tract infection, haematuria on May 12, 2010 from BRAZIL Additional patient health information: Female patient , child 5 years of age, was diagnosed with niemann-pick disease and. Zavesca dosage: 4 Mg/kg, Od. During the same period patient was treated with PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ). Patient was hospitalized.

6743095-2 | Disease Progression, Gaucher's Disease, Off Label Use
Adverse event was reported on May 11, 2010 by a Male patient taking Zavesca (View Usage) (Dosage: 33 Mg, Tid, Oral) was diagnosed with gaucher's disease and. Location: GERMANY , weighting 16.09 lb, After Zavesca was administered, patient had the following side effects: disease progression, gaucher's disease, off label use.

6691397-0 | Myocardial Infarction
on Apr 06, 2010 Male patient from GERMANY , 62 years of age, was diagnosed with gaucher's disease and was treated with Zavesca (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction. Zavesca dosage: Oral.

6669795-0 | Abdominal Pain Upper, Adenocarcinoma Pancreas, Constipation, Fatigue, Jaundice, Weight Decreased
on Mar 22, 2010 Male patient from NETHERLANDS , 63 years of age, was diagnosed with gaucher's disease and was treated with Zavesca (View Usage). Patient had the following side effects: abdominal pain upper, adenocarcinoma pancreas, constipation (What is constipation?), fatigue, jaundice (What is jaundice?), weight decreased. Zavesca dosage: 100 Mg, Tid, Oral. During the same period patient was treated with PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), PANTAZOL (PANTOPRAZOLE SODIUM) (View Pantazol (pantoprazole Sodium) Review and Pantazol (pantoprazole Sodium) Label ), MONOCEDOCARD (ISOSORBIDE MONONITRATE) (View Monocedocard (isosorbide Mononitrate) Review and Monocedocard (isosorbide Mononitrate) Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), PANZYTRAT (PANCREATIN) (View Panzytrat (pancreatin) Review and Panzytrat (pancreatin) Label ), NOVOMIX (INSULIN ASPART PROTAMINE (CRYSTALLINE), INSULIN ASPART (View Novomix (insulin Aspart Protamine (crystalline), Insulin Aspart Review and Novomix (insulin Aspart Protamine (crystalline), Insulin Aspart Label ). Patient was hospitalized and became disabled.

6651746-6 | Aspartate Aminotransferase Increased, Aspiration, Bronchial Obstruction, Convulsion, Diarrhoea, Haematochezia, Pancytopenia, Respiratory Syncytial Virus Test Positive, Reticulocyte Count Decreased
Patient was taking Zavesca (View Usage). After Zavesca was administered, patient had the following side effects: aspartate aminotransferase increased, aspiration, bronchial obstruction, convulsion, diarrhoea, haematochezia, pancytopenia, respiratory syncytial virus test positive, reticulocyte count decreased on Mar 09, 2010 from FRANCE Additional patient health information: Male patient , child 2 years of age, weighting 22.05 lb, was diagnosed with niemann-pick disease and. Zavesca dosage: 50 Mg, Tid, Oral; 25 Mg, Bid, Oral. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6644567-1 | Abdominal Pain Upper, Abnormal Faeces, Adenocarcinoma Pancreas, Constipation, Fatigue, Jaundice, Weight Decreased
Adverse event was reported on Mar 05, 2010 by a Male patient taking Zavesca (View Usage) (Dosage: 100 Mg, Tid, Oral) was diagnosed with gaucher's disease and. Location: NETHERLANDS , 63 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain upper, abnormal faeces, adenocarcinoma pancreas, constipation (What is constipation?), fatigue, jaundice (What is jaundice?), weight decreased. During the same period patient was treated with PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), PANTAZOL (PANTOPRAZOLE SODIUM) (View Pantazol (pantoprazole Sodium) Review and Pantazol (pantoprazole Sodium) Label ), MONOCEDOCARD (ISOSORBIDE MONONITRATE) (View Monocedocard (isosorbide Mononitrate) Review and Monocedocard (isosorbide Mononitrate) Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), PANZYTRAT (PANCREATIN) (View Panzytrat (pancreatin) Review and Panzytrat (pancreatin) Label ), NOVOMIX (INSULIN ASPART PROTAMINE (CRYSTALLINE), INSULIN ASPART) (View Novomix (insulin Aspart Protamine (crystalline), Insulin Aspart) Review and Novomix (insulin Aspart Protamine (crystalline), Insulin Aspart) Label ). Patient was hospitalized and became disabled.

6639129-6 | Bone Pain
on Mar 01, 2010 Male patient from GREECE , 35 years of age, was diagnosed with gaucher's disease and was treated with Zavesca (View Usage). Patient had the following side effects: bone pain. Zavesca dosage: 100 Mg, Tid, Oral. Patient was hospitalized.

6638722-4 | Arthritis, Hepatic Fibrosis, Hepatitis B Positive, Pain
on Mar 02, 2010 Male patient from GREECE , 35 years of age, was diagnosed with gaucher's disease and was treated with Zavesca (View Usage). After Zavesca was administered, patient had the following side effects: arthritis (What is arthritis?), hepatic fibrosis, hepatitis b positive, pain (What is pain?). Zavesca dosage: 100 Mg, Tid, Oral. During the same period patient was treated with ZOMETA (View Zometa Review and Zometa Label ).

6613759-X | Aphasia, Asthenia, Dysphagia, Fatigue, Gastrostomy, Immobile, Malaise, Mobility Decreased
Patient was taking Zavesca (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), asthenia, dysphagia, fatigue, gastrostomy, immobile, malaise, mobility decreased on Feb 15, 2010 from UNITED KINGDOM Additional patient health information: Male patient , child 4 years of age, weighting 30.86 lb, was diagnosed with niemann-pick disease and. Zavesca dosage: 100 Mg, Bid, Oral.

6611592-6 | Arthritis, Blood Bilirubin Increased, Chronic Hepatitis, Hepatic Fibrosis, Hepatitis B Positive, Pain
Adverse event was reported on Feb 09, 2010 by a Male patient taking Zavesca (View Usage) (Dosage: 100 Mg, Tid, Oral 100 Mg, Od, Oral) was diagnosed with gaucher's disease and. Location: GREECE , 35 years of age, Patient had the following side effects: arthritis (What is arthritis?), blood bilirubin increased, chronic hepatitis, hepatic fibrosis, hepatitis b positive, pain (What is pain?). During the same period patient was treated with ZOMETA (ZOLENDRONIC) (View Zometa (zolendronic) Review and Zometa (zolendronic) Label ).

6609212-X | Asthenia, Fatigue, Fibromyalgia, Gastrointestinal Inflammation, Haematocrit Decreased, Irritable Bowel Syndrome, Large Intestinal Ulcer, Osteopenia, Plantar Fasciitis
on Feb 16, 2010 Female patient from UNITED STATES , 49 years of age, weighting 194.0 lb, was diagnosed with gaucher's disease and was treated with Zavesca (View Usage). After Zavesca was administered, patient had the following side effects: asthenia, fatigue, fibromyalgia, gastrointestinal inflammation, haematocrit decreased, irritable bowel syndrome (What is irritable bowel syndrome?), large intestinal ulcer, osteopenia, plantar fasciitis. Zavesca dosage: 100 Mg, Tid, Oral; 100 Mg, Tid, Oral. During the same period patient was treated with LEXAPRO (View Lexapro Review and Lexapro Label ), MOTRIN (View Motrin Review and Motrin Label ), TYLENOL (View Tylenol Review and Tylenol Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), AMBIEN (View Ambien Review and Ambien Label ). Patient was hospitalized.

6589551-1 | Escherichia Urinary Tract Infection
on Feb 02, 2010 Female patient from BRAZIL , child 5 years of age, was diagnosed with niemann-pick disease and was treated with Zavesca (View Usage). Patient experienced the following unwanted or unexpected effects: escherichia urinary tract infection. Zavesca dosage: . During the same period patient was treated with PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ). Patient was hospitalized.

6571247-3 | Purpura, Vaccination Complication
Patient was taking Zavesca (View Usage). Patient had the following side effects: purpura, vaccination complication on Jan 19, 2010 from GREECE Additional patient health information: Female patient , child 1 years of age, was diagnosed with niemann-pick disease and. Zavesca dosage: 100 Mg, Oral. During the same period patient was treated with PRIORIX(MEASLES, MUMPS AND RUBELLA VACCINE) (View Priorix(measles, Mumps And Rubella Vaccine) Review and Priorix(measles, Mumps And Rubella Vaccine) Label ), VAXIGRIP (INFLUENZA VACCINE INACTIVATED) (View Vaxigrip (influenza Vaccine Inactivated) Review and Vaxigrip (influenza Vaccine Inactivated) Label ).

6528818-X | Adenocarcinoma Pancreas
Adverse event was reported on Dec 15, 2009 by a Male patient taking Zavesca (View Usage) (Dosage: 100 Mg, Tid, Oral) was diagnosed with gaucher's disease and. Location: NETHERLANDS , 63 years of age, After Zavesca was administered, patient had the following side effects: adenocarcinoma pancreas. During the same period patient was treated with PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), PANTAZOL (PANTOPRAZOLE SODIUM) (View Pantazol (pantoprazole Sodium) Review and Pantazol (pantoprazole Sodium) Label ), MONOCEDOCARD (ISOSORBIDE MONONITRATE) (View Monocedocard (isosorbide Mononitrate) Review and Monocedocard (isosorbide Mononitrate) Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), PANZYTRAT (PANCREATIN) (View Panzytrat (pancreatin) Review and Panzytrat (pancreatin) Label ), NOVOMIX (INSULIN ASPART PROTAMINE (CRYSTALLINE), INSULIN ASPART) (View Novomix (insulin Aspart Protamine (crystalline), Insulin Aspart) Review and Novomix (insulin Aspart Protamine (crystalline), Insulin Aspart) Label ). Patient was hospitalized and became disabled.

6526421-9 | Asthenia, Constipation, Diarrhoea, Fatigue, Gastrointestinal Inflammation, Large Intestinal Ulcer, Plantar Fasciitis
on Dec 21, 2009 Female patient from UNITED STATES , 49 years of age, weighting 194.0 lb, was diagnosed with gaucher's disease and was treated with Zavesca (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, constipation (What is constipation?), diarrhoea, fatigue, gastrointestinal inflammation, large intestinal ulcer, plantar fasciitis. Zavesca dosage: 100 Mg, Tid, Oral. During the same period patient was treated with LEXAPRO (View Lexapro Review and Lexapro Label ), MOTRIN (View Motrin Review and Motrin Label ), TYLENOL (View Tylenol Review and Tylenol Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), AMBIEN (View Ambien Review and Ambien Label ). Patient was hospitalized.

6447972-1 | Anaemia, Platelet Count Decreased, White Blood Cell Count Decreased
on Nov 06, 2009 Female patient from UNITED KINGDOM , 66 years of age, weighting 158.7 lb, was diagnosed with gaucher's disease and was treated with Zavesca (View Usage). Patient had the following side effects: anaemia, platelet count decreased, white blood cell count decreased. Zavesca dosage: 100 Mg, Bid, Oral; 100 Mg, Od, Oral.

6427990-X | Abdominal Pain, Back Pain, Bone Pain, Diarrhoea, Epilepsy, Myoclonus, Osteopenia, Pyrexia
Patient was taking Zavesca (View Usage). After Zavesca was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), back pain (What is back pain?), bone pain, diarrhoea, epilepsy (What is epilepsy?), myoclonus, osteopenia, pyrexia on Oct 16, 2009 from FRANCE Additional patient health information: Male patient , 29 years of age, weighting 185.2 lb, was diagnosed with gaucher's disease and. Zavesca dosage: 100 Mg, Bid, Oral; 100 Mg, Qd, Oral; 100 Mg, Tid, Oral; 400 Mg, Qd,. During the same period patient was treated with CEREZYME (View Cerezyme Review and Cerezyme Label ), IMODIUM (View Imodium Review and Imodium Label ), ZONEGRAN (View Zonegran Review and Zonegran Label ), DEPAKENE (View Depakene Review and Depakene Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ). Patient was hospitalized.

6416920-2 | Arthralgia, Joint Swelling
Adverse event was reported on Oct 15, 2009 by a Female patient taking Zavesca (View Usage) (Dosage: 100 Mg, Tid, Oral) was diagnosed with gaucher's disease and. Location: BRAZIL , 30 years of age, Patient experienced the following unwanted or unexpected effects: arthralgia, joint swelling. During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ).

6390927-6 | Arthralgia, Joint Swelling
on Sep 22, 2009 Female patient from BRAZIL , 30 years of age, was diagnosed with gaucher's disease and was treated with Zavesca (View Usage). Patient had the following side effects: arthralgia, joint swelling. Zavesca dosage: 100 Mg, Tid, Oral; Oral. During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ).

6387445-8 | Diarrhoea, Respiratory Failure
on Sep 15, 2009 Female patient from UNITED STATES , 20 years of age, was diagnosed with niemann-pick disease and was treated with Zavesca (View Usage). After Zavesca was administered, patient had the following side effects: diarrhoea, respiratory failure. Zavesca dosage: Oral.

6358415-0 | Sleep Apnoea Syndrome, Sleep Disorder
Patient was taking Zavesca (View Usage). Patient experienced the following unwanted or unexpected effects: sleep apnoea syndrome, sleep disorder (What is sleep disorder?) on Aug 28, 2009 from GERMANY Additional patient health information: Male patient , 20 years of age, was diagnosed with niemann-pick disease and. Zavesca dosage: 100 Mg, Tid, Oral ; 200 Mg, Tid, Oral. During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), KEPPRA (View Keppra Review and Keppra Label ), VITAMIN NOS (VITAMINS NOS) (View Vitamin Nos (vitamins Nos) Review and Vitamin Nos (vitamins Nos) Label ). Patient was hospitalized.

6315632-3 | Respiratory Arrest, Sleep Apnoea Syndrome, Sleep Disorder
Adverse event was reported on Aug 05, 2009 by a Male patient taking Zavesca (View Usage) (Dosage: 100 Mg, Tid, Oral; 200 Mg, Tid, Oral) was diagnosed with niemann-pick disease and. Location: GERMANY , 20 years of age, Patient had the following side effects: respiratory arrest, sleep apnoea syndrome, sleep disorder (What is sleep disorder?). During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), KEPPRA (View Keppra Review and Keppra Label ), VITAMINS NOS (VITAMINS NOS) (View Vitamins Nos (vitamins Nos) Review and Vitamins Nos (vitamins Nos) Label ). Patient was hospitalized.

6307986-9 |
on Sep 24, 2008 Female patient from UNITED STATES , 20 years of age, was diagnosed with niemann-pick disease and was treated with Zavesca (View Usage). . Zavesca dosage: Oral.

6295015-5 | Aspartate Aminotransferase Increased, Aspiration, Bronchial Obstruction, C-reactive Protein Increased, Diarrhoea, Pancytopenia, Pyrexia
on Jul 15, 2009 Male patient from FRANCE , child 2 years of age, weighting 22.05 lb, was diagnosed with niemann-pick disease and was treated with Zavesca (View Usage). Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, aspiration, bronchial obstruction, c-reactive protein increased, diarrhoea, pancytopenia, pyrexia. Zavesca dosage: 50 Mg, Tid, Oral; 25 Mg, Bid, Oral. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6274257-9 | Aspiration, Bronchial Obstruction, Diarrhoea, Pancytopenia, Pyrexia
Patient was taking Zavesca (View Usage). Patient had the following side effects: aspiration, bronchial obstruction, diarrhoea, pancytopenia, pyrexia on Jul 03, 2009 from FRANCE Additional patient health information: Male patient , child 2 years of age, weighting 22.05 lb, was diagnosed with niemann-pick disease and. Zavesca dosage: 50 Mg Tid,oral 25 Mg, Bid,oral. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6157130-6 | Abdominal Pain, Bone Pain, Diarrhoea, Osteolysis, Spinal Compression Fracture
Adverse event was reported on Mar 30, 2009 by a Male patient taking Zavesca (View Usage) (Dosage: 100 Mg, Bid ; 100 Mg, Qd, Oral) was diagnosed with gaucher's disease and. Location: FRANCE , 48 years of age, weighting 132.3 lb, After Zavesca was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), bone pain, diarrhoea, osteolysis, spinal compression fracture. During the same period patient was treated with CLASTOBAN (CLODRONATE DISODIUM) (View Clastoban (clodronate Disodium) Review and Clastoban (clodronate Disodium) Label ), COMBIVIR (View Combivir Review and Combivir Label ), SUSTIVA (View Sustiva Review and Sustiva Label ). Patient was hospitalized and became disabled.

6091155-4 | Chitotriosidase Increased, Osteonecrosis
on Feb 05, 2009 Male patient from SWEDEN , 28 years of age, weighting 194.0 lb, was diagnosed with gaucher's disease and was treated with Zavesca (View Usage). Patient experienced the following unwanted or unexpected effects: chitotriosidase increased, osteonecrosis (What is osteonecrosis?). Zavesca dosage: 100 Mg, Tid, Oral.

6062577-2 | Chitotriosidase Increased, Osteonecrosis
on Jan 14, 2009 Male patient from SWEDEN , 28 years of age, weighting 194.0 lb, was diagnosed with gaucher's disease and was treated with Zavesca (View Usage). Patient had the following side effects: chitotriosidase increased, osteonecrosis (What is osteonecrosis?). Zavesca dosage: 100 Mg, Tid; Oral.

6043331-4 | Abdominal Distension, Asthenia, Constipation, Diarrhoea, Fatigue, Flatulence, Gastrointestinal Inflammation, Large Intestinal Ulcer
Patient was taking Zavesca (View Usage). After Zavesca was administered, patient had the following side effects: abdominal distension, asthenia, constipation (What is constipation?), diarrhoea, fatigue, flatulence, gastrointestinal inflammation, large intestinal ulcer on Dec 31, 2008 from UNITED STATES Additional patient health information: Female patient , 49 years of age, weighting 194.0 lb, was diagnosed with gaucher's disease and. Zavesca dosage: 100 Mig, Tid, Oral. During the same period patient was treated with LEXAPRO (View Lexapro Review and Lexapro Label ), MOTRIN (View Motrin Review and Motrin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), AMBIEN (View Ambien Review and Ambien Label ).

6039469-8 | Abdominal Distension, Asthenia, Constipation, Diarrhoea, Fatigue, Flatulence, Gastrointestinal Inflammation
Adverse event was reported on Dec 31, 2008 by a Female patient taking Zavesca (View Usage) (Dosage: 100 Mg, Tid, Oral) was diagnosed with gaucher's disease and. Location: UNITED STATES , 49 years of age, weighting 194.0 lb, Patient experienced the following unwanted or unexpected effects: abdominal distension, asthenia, constipation (What is constipation?), diarrhoea, fatigue, flatulence, gastrointestinal inflammation. During the same period patient was treated with LEXAPRO (View Lexapro Review and Lexapro Label ), MOTRIN (View Motrin Review and Motrin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), AMBIEN (View Ambien Review and Ambien Label ).

5914510-9 | Acute Respiratory Failure, Disease Progression, Febrile Convulsion, Niemann-pick Disease
on Sep 22, 2008 Male patient from BRAZIL , child 3 years of age, was diagnosed with niemann-pick disease and was treated with Zavesca (View Usage). Patient had the following side effects: acute respiratory failure, disease progression, febrile convulsion, niemann-pick disease. Zavesca dosage: 100 Mg, Tid, Oral. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ).

5903115-1 | Demyelination, Diarrhoea, Tremor
on Sep 15, 2008 Male patient from ITALY , 53 years of age, weighting 187.4 lb, was diagnosed with electroneurography and was treated with Zavesca (View Usage). After Zavesca was administered, patient had the following side effects: demyelination, diarrhoea, tremor. Zavesca dosage: 500 Mg, Od, Oral; 300 Mg, Od, Oral. During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), KCL TAB (View Kcl Tab Review and Kcl Tab Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), NEXIUM (ESOMEPRAZOLE SODIUM) (View Nexium (esomeprazole Sodium) Review and Nexium (esomeprazole Sodium) Label ), TANSULOSINA (TAMSULOSIN) (View Tansulosina (tamsulosin) Review and Tansulosina (tamsulosin) Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ).

5875997-3 | Demyelination, Diarrhoea, Motor Dysfunction, Tremor
Patient was taking Zavesca (View Usage). Patient experienced the following unwanted or unexpected effects: demyelination, diarrhoea, motor dysfunction, tremor on Aug 26, 2008 from ITALY Additional patient health information: Male patient , 53 years of age, weighting 187.4 lb, was diagnosed with lipidosis and. Zavesca dosage: 500 Mg, Od, Oral. During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), KCL TAB (View Kcl Tab Review and Kcl Tab Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), NEXIUM (ESOMEPRAZOLE SODIUM) (View Nexium (esomeprazole Sodium) Review and Nexium (esomeprazole Sodium) Label ), TANSULOSINA (TAMSULOSIN) (View Tansulosina (tamsulosin) Review and Tansulosina (tamsulosin) Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ).

5839384-6 | Colonic Polyp, Gastrointestinal Tract Adenoma, Intestinal Polyp
Adverse event was reported on Jul 24, 2008 by a Female patient taking Zavesca (View Usage) (Dosage: 100 Mg, Tid, Oral) was diagnosed with gaucher's disease and. Location: SOUTH AFRICA , 63 years of age, Patient had the following side effects: colonic polyp (What is colonic polyp?), gastrointestinal tract adenoma, intestinal polyp.

5776266-2 | Abasia, Disease Progression, Intestinal Perforation, Muscular Weakness, Off Label Use, Progressive Muscular Atrophy, Repair Of Imperforate Rectum, Tremor
on May 30, 2008 Female patient from UNITED STATES , child 12 years of age, was diagnosed with gaucher's disease and was treated with Zavesca (View Usage). After Zavesca was administered, patient had the following side effects: abasia, disease progression, intestinal perforation, muscular weakness, off label use, progressive muscular atrophy, repair of imperforate rectum, tremor. Zavesca dosage: Oral.

5646475-1 | Prostatitis
on Feb 13, 2008 Male patient from FRANCE , 72 years of age, weighting 143.3 lb, was diagnosed with gaucher's disease and was treated with Zavesca (View Usage). Patient experienced the following unwanted or unexpected effects: prostatitis. Zavesca dosage: 100 Mg, Tid, Oral. During the same period patient was treated with CEREZYME (IMIGLUCERASE) (View Cerezyme (imiglucerase) Review and Cerezyme (imiglucerase) Label ), MADOPAR (BENSERAZIDE, LEVODOPA) (View Madopar (benserazide, Levodopa) Review and Madopar (benserazide, Levodopa) Label ), SINEMET (View Sinemet Review and Sinemet Label ), EXELON (View Exelon Review and Exelon Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), CALCIUM D3 (COLECALCIFEROL, CALCIUM) (View Calcium D3 (colecalciferol, Calcium) Review and Calcium D3 (colecalciferol, Calcium) Label ). Patient was hospitalized.

5599522-X | Convulsion
Patient was taking Zavesca (View Usage). Patient had the following side effects: convulsion on Nov 26, 2007 from UNITED STATES Additional patient health information: Male patient , child 6 years of age, was diagnosed with gaucher's disease and. Zavesca dosage: 100 Mg, Bid, Oral.